GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (FRA:25I) » Definitions » Other Liabilities for Banks

ImmuPharma (FRA:25I) Other Liabilities for Banks


View and export this data going back to 2017. Start your Free Trial

What is ImmuPharma Other Liabilities for Banks?

Other Liabilities (Bank) only applies to banks.


ImmuPharma Business Description

Industry
Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.